<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Clin Cancer Res</journal-id><journal-title>Journal of Experimental &#x00026; Clinical Cancer Research : CR</journal-title><issn pub-type="ppub">0392-9078</issn><issn pub-type="epub">1756-9966</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1756-9966-28-90</article-id><article-id pub-id-type="pmid">19558691</article-id><article-id pub-id-type="doi">10.1186/1756-9966-28-90</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title><italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T variants are not associated with overweight condition or with tumors/cancer in Italians &#x02013; a case-control study</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Meenakshisundaram</surname><given-names>Ramachandran</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rmsundar_chandran@yahoo.co.in</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Piumelli</surname><given-names>Nunzia</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>n.piumelli@libero.it</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Pierpaoli</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>laura.pierpaoli@inwind.it</email></contrib><contrib id="A4" corresp="yes" contrib-type="author"><name><surname>Gragnoli</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I5">5</xref><email>claudia.gragnoli@gmail.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Medicine and Cellular &#x00026; Molecular Physiology and Biostatistics, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA</aff><aff id="I2"><label>2</label>Penn State University College of Medicine, Hershey, Pennsylvania, USA</aff><aff id="I3"><label>3</label>Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Philadelphia, Pennsylvania, USA</aff><aff id="I4"><label>4</label>Department of Biology, Temple University's College of Science &#x00026; Technology, Philadelphia, PA, USA</aff><aff id="I5"><label>5</label>Molecular Biology Laboratory, Bios Biotech Multi-Diagnostic Health Center, Rome, Italy</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>26</day><month>6</month><year>2009</year></pub-date><volume>28</volume><issue>1</issue><fpage>90</fpage><lpage>90</lpage><ext-link ext-link-type="uri" xlink:href="http://www.jeccr.com/content/28/1/90"/><history><date date-type="received"><day>1</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>26</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Meenakshisundaram et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Meenakshisundaram et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Meenakshisundaram Ramachandran rmsundar_chandran@yahoo.co.in </dc:author><dc:title> CHOP 5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T variants are not associated with overweight condition or with tumors/cancer in Italians &#x02013; a case-control study </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Journal of Experimental &#x00026; Clinical Cancer Research 28(1): 90-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1756-9966(2009)28:1&#x0003c;90&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1756-9966</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Type 2 diabetes (T2D) is associated with obesity and has been shown recently to be associated with tumors/cancer. <italic>HNF1-beta </italic>and <italic>JAZF1 </italic>genes are associated with T2D and prostate cancer. We have previously shown that <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T haplotype variants contribute to T2D. CHOP deficiency causes obesity in mice, thus <italic>CHOP </italic>gene variants may contribute to human obesity. Furthermore, <italic>CHOP </italic>mediates apoptosis and is implicated in cancer pathogenesis. Hence, we aimed at identifying any potential association of <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotypes and corresponding haplotypes with overweight condition/pre-obesity and tumors/cancer in an Italian dataset.</p></sec><sec sec-type="methods"><title>Methods</title><p>We recruited from Italy 45 overweight subjects (body mass index (BMI) &#x02265; 25) and 44 control subjects (BMI &#x0003c; 25) as well as 54 cases with at least one cancer or at least one tumor and 43 control subjects without tumors/cancer from the general population. We excluded allelic departure from Hardy-Weinberg equilibrium in cases and control subjects, separately.</p></sec><sec><title>Results</title><p>We assessed the power to detect risk odds ratios by association tests in our datasets. We tested the hypothesis of association of CHOP 5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotypes and haplotypes with tumors/cancer and, separately, with overweight condition. Both associations were not significant.</p></sec><sec><title>Conclusion</title><p>From our study, we may conclude that <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotypes and corresponding haplotypes are not associated with tumors/cancer and pre-obesity. However, more studies are warranted to establish the role of <italic>CHOP </italic>variants in tumor/cancer predisposition and in overweight condition.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Type 2 diabetes (T2D) is associated with obesity. There is increasing evidence that T2D is associated with tumors [<xref ref-type="bibr" rid="B1">1</xref>] and cancers of the pancreas [<xref ref-type="bibr" rid="B2">2</xref>], prostate, breast, colon, endometrium, and liver [<xref ref-type="bibr" rid="B3">3</xref>]. T2D genes, such as <italic>HNF-1 beta </italic>and <italic>JAZF1</italic>, have been associated with prostate cancer [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Thus, T2D candidate genes may not only be obesity predisposing genes, but also tumor/cancer risk genes. CHOP mediates apoptosis and regulates mitochondrial gene expression, thus it may be implicated in beta cell inability to replicate as well as in insulin secretion defects. Following up on a linkage signal in the <italic>CHOP </italic>region of chromosome 12q13.1 in Italian T2D families, we have previously shown that <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T haplotype variants are associated with early-onset T2D under a recessive and additive model [<xref ref-type="bibr" rid="B7">7</xref>]. In addition, CHOP inhibits adipogenesis [<xref ref-type="bibr" rid="B8">8</xref>], thus <italic>CHOP </italic>gene variants may contribute to insulin resistance [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>] and/or obesity [<xref ref-type="bibr" rid="B11">11</xref>]. Since CHOP is regulating programmed cell death in response to stress stimuli [<xref ref-type="bibr" rid="B12">12</xref>], it is implicated in tumor/cancer development.</p><p>CHOP is involved in the pathogenesis of myxoid liposarcoma, a rare human tumor in which a reciprocal chromosomal translocation creates a fusion protein consisting of CHOP and TLS, a potent oncoprotein [<xref ref-type="bibr" rid="B13">13</xref>]. Other tumor-specific fusion genes, such as <italic>EWS-CHOP </italic>and <italic>TLS/FUS-CHOP</italic>, have been detected in solid tumors [<xref ref-type="bibr" rid="B14">14</xref>] and liposarcomas [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. Another rearrangement of the <italic>CHOP </italic>gene has been reported in myxoid liposarcoma [<xref ref-type="bibr" rid="B18">18</xref>].</p><p>Our aim was to find whether there is any association of the <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotypes and corresponding haplotypes (the latter contributing to T2D) [<xref ref-type="bibr" rid="B7">7</xref>] with body mass index (BMI) &#x02265; 25 (hereby defined as overweight condition/pre-obesity) and/or with tumors/cancer in an Italian dataset.</p></sec><sec sec-type="methods"><title>Methods</title><p>We recruited from the general population in Italy 45 subjects with BMI &#x02265; 25 and 44 control subjects with BMI &#x0003c; 25 and 54 subjects with at least one cancer or at least one tumor and 43 control subjects with no history of tumor or cancer. We obtained the written informed consent from each subject and the approval from the Institutional Review Board accordingly to Helsinki Declaration guidelines. DNA samples were directly sequenced by PCR and an automated fluorescence sequencer with specific primers for the <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotypes.</p><p>We calculated via 70% power and type 1 error probability of 0.05, detectable odds ratios for genotype association tests in our two datasets, using the prevalence of 31.3% for overweight condition [<xref ref-type="bibr" rid="B19">19</xref>] and the prevalence of 2.7% for tumors/cancer in the Italian population [<xref ref-type="bibr" rid="B20">20</xref>].</p><p>Via Chi-Square test statistics, we tested the alleles for departure from Hardy-Weinberg equilibrium (HWE) in our two datasets in cases and control subject groups, separately.</p><p>Via the Mantel-Haenszel algorithm, we tested the <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotypes for association with BMI &#x02265; 25 and with tumors/cancer.</p><p>In addition, we performed model free and parametric haplotype associations tests (dominant, recessive and additive models) for BMI &#x02265; 25 and for tumors/cancer, independently (EHPLUS software) [<xref ref-type="bibr" rid="B21">21</xref>].</p></sec><sec><title>Results</title><p>Risk odds ratios of 0.248/2.943 for genotypes association tests were detectable in the pre-obesity dataset. Risk odds ratios of 8.210 for genotype association tests were detectable in the tumors/cancer dataset.</p><p>All alleles tested in each group of the two datasets of BMI &#x02265; 25 and of tumors/cancer were not in departure from HWE.</p><p>We did not identify in our dataset any significant and valid association of the <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotype variants with BMI &#x02265; 25 (Table <xref ref-type="table" rid="T1">1</xref>) as well as with tumors/cancer patients (Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p><italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotype association with overweight condition (BMI &#x02265; 25).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Genotype</bold></td><td align="left" colspan="2"><bold>45 Cases</bold></td><td align="left" colspan="2"><bold>44 Control Subjects</bold></td><td align="left"><bold>&#x003c7;<sup>2</sup></bold></td><td align="left"><bold>2-t P</bold></td><td align="left"><bold>OR</bold></td><td align="left"><bold>95% C.I</bold>.</td></tr></thead><tbody><tr><td align="left"><bold>5'UTRc.279T&#x0003e;C</bold></td><td align="left">+</td><td align="left">-</td><td align="left">+</td><td align="left">-</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">TT</td><td align="left">31</td><td align="left">14</td><td align="left">26</td><td align="left">18</td><td align="left">0.92</td><td align="left">0.33</td><td align="left">1.53</td><td align="left">0.59&#x02013;4.02</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">CT</td><td align="left">13</td><td align="left">32</td><td align="left">18</td><td align="left">26</td><td align="left">1.41</td><td align="left">0.23</td><td align="left">0.59</td><td align="left">0.22&#x02013;1.55</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">CC</td><td align="left">1</td><td align="left">44</td><td align="left">0</td><td align="left">44</td><td align="left">0.98</td><td align="left">0.32</td><td align="left">8</td><td align="left">0.06&#x02013;8</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left"><bold>+nt30C&#x0003e;T</bold></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">TT</td><td align="left">0</td><td align="left">45</td><td align="left">0</td><td align="left">44</td><td></td><td></td><td align="left">NA</td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">CT</td><td align="left">13</td><td align="left">32</td><td align="left">17</td><td align="left">27</td><td align="left">0.94</td><td align="left">0.33</td><td align="left">0.65</td><td align="left">0.24&#x02013;1.71</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">CC</td><td align="left">32</td><td align="left">13</td><td align="left">27</td><td align="left">17</td><td align="left">0.94</td><td align="left">0.33</td><td align="left">1.55</td><td align="left">0.58&#x02013;4.13</td></tr></tbody></table><table-wrap-foot><p>X<sup>2 </sup>= Chi-Square, 2-t P = 2-tailed p-value, OR = odds ratio,</p><p>C.I. = confidence interval</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p><italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotype association with tumors/cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Genotype</bold></td><td align="left" colspan="2"><bold>54 Cases</bold></td><td align="left" colspan="2"><bold>43 Control Subjects</bold></td><td align="left"><bold>&#x003c7;<sup>2</sup></bold></td><td align="left"><bold>2-t P</bold></td><td align="left"><bold>OR</bold></td><td align="left"><bold>95% C.I</bold>.</td></tr></thead><tbody><tr><td align="left"><bold>5'UTRc.279T&#x0003e;C</bold></td><td align="left">+</td><td align="left">-</td><td align="left">+</td><td align="left">-</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">TT</td><td align="left">35</td><td align="left">19</td><td align="left">27</td><td align="left">16</td><td align="left">0.04</td><td align="left">0.83</td><td align="left">1.09</td><td align="left">0.44&#x02013;2.73</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">CT</td><td align="left">17</td><td align="left">37</td><td align="left">14</td><td align="left">29</td><td align="left">0.01</td><td align="left">0.91</td><td align="left">0.95</td><td align="left">0.37&#x02013;2.45</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">CC</td><td align="left">2</td><td align="left">52</td><td align="left">2</td><td align="left">41</td><td align="left">0.05</td><td align="left">0.81</td><td align="left">0.79</td><td align="left">0.08&#x02013;8.28</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left"><bold>+nt30C&#x0003e;T</bold></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">TT</td><td align="left">2</td><td align="left">52</td><td align="left">1</td><td align="left">42</td><td align="left">0.15</td><td align="left">0.69</td><td align="left">1.62</td><td align="left">0.11&#x02013;46.73</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">CT</td><td align="left">17</td><td align="left">37</td><td align="left">16</td><td align="left">27</td><td align="left">0.35</td><td align="left">0.55</td><td align="left">0.78</td><td align="left">0.31&#x02013;1.96</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">CC</td><td align="left">35</td><td align="left">19</td><td align="left">26</td><td align="left">17</td><td align="left">0.19</td><td align="left">0.66</td><td align="left">1.20</td><td align="left">0.48&#x02013;2.99</td></tr></tbody></table><table-wrap-foot><p>X<sup>2 </sup>= Chi-Square, 2-t P = 2-tailed p-value, OR = odds ratio,</p><p>C.I. = confidence interval</p></table-wrap-foot></table-wrap><p>The parametric and non-parametric <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T haplotype association tests with BMI &#x02265; 25 as well as with tumors/cancer were also not significant (data not shown).</p></sec><sec><title>Discussion</title><p><italic>CHOP </italic>gene encodes a C/EBP (CCAAT/enhancer binding protein family)-homologous nuclear protein that acts as dominant-negative inhibitor of gene transcription through dimerization with C/EBP [<xref ref-type="bibr" rid="B22">22</xref>]. <italic>CHOP </italic>is implicated in programmed cell death [<xref ref-type="bibr" rid="B12">12</xref>]. Several studies reported <italic>CHOP </italic>gene rearrangement and/or fusion with other genes (such as <italic>EWS-CHOP </italic>and <italic>TLS/FUS-CHOP</italic>) in tumors/cancer [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B18">18</xref>].</p><p>Cellular and endoplasmic reticulum (ER) stress, occurring in response to toxic and metabolic insult, is a powerful inducer of CHOP [<xref ref-type="bibr" rid="B12">12</xref>]. ER stress down-regulates insulin receptor signaling and triggers insulin resistance [<xref ref-type="bibr" rid="B9">9</xref>]. Furthermore, insulin increases <italic>CHOP </italic>expression in adipocyte cells [<xref ref-type="bibr" rid="B23">23</xref>], and CHOP inhibits adipocyte differentiation [<xref ref-type="bibr" rid="B8">8</xref>]. Thus, CHOP deficiency may contribute to obesity [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>Glucotoxicity induces cellular stress [<xref ref-type="bibr" rid="B24">24</xref>], which activates CHOP [<xref ref-type="bibr" rid="B12">12</xref>]. Thus, hyperglycemia may cause CHOP-mediated beta-cell apoptosis and may contribute to T2D. Interestingly, <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T haplotype variants are significantly associated with early-onset T2D under a recessive and additive model [<xref ref-type="bibr" rid="B7">7</xref>]. For all the above reasons, <italic>CHOP </italic>is not only a T2D gene, but it is also an obesity candidate gene as well as a gene potentially predisposing to tumors and/or cancer. Other T2D genes, such as <italic>HNF-1 beta </italic>and <italic>JAZF1</italic>, have already been associated with prostate cancer [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Of note, while the prostate cancer risk <italic>HNF-1 beta </italic>variant decreases the risk of T2D [<xref ref-type="bibr" rid="B4">4</xref>], variants of <italic>JAZF1 </italic>gene are associated with both increased risk for T2D and for prostate cancer [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p><p>However, no study has up to date investigated the susceptibility role of <italic>CHOP </italic>common variants in pre-obese and tumor/cancer patients. This is the first association study focusing on <italic>CHOP </italic>gene variants in human genomic DNA samples of overweight subjects and tumor/cancer cases.</p><p>In our study, we did not identify any association between <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T genotype and haplotype variants with pre-obesity and with tumors/cancer. If the <italic>CHOP </italic>gene variants tested were to contribute to overweight condition and/or tumors/cancer with a modest size effect, our datasets are too small to detect such effects. However, we could at least exclude in the current study a <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T variant risk effect of about 3 for pre-obesity and of about 8 for tumors/cancer.</p></sec><sec><title>Conclusion</title><p>In summary, we conclude that <italic>CHOP </italic>5'UTR-c.279T&#x0003e;C and +nt30C&#x0003e;T variants, both at genotype and at haplotype level, are not contributing to the overweight condition and tumors/cancer in our dataset. However, other studies are warranted to further exclude the role of any other <italic>CHOP </italic>variants in obesity and in tumor/cancer predisposition. Since obesity is a preventable associated factor in several tumors/cancer [<xref ref-type="bibr" rid="B25">25</xref>] and in other co-morbidities [<xref ref-type="bibr" rid="B26">26</xref>], and, since tumors and cancer may be prevented and/or diagnosed at an earlier stage, genetic studies to identity overweight risk predisposition as well as tumors/cancer risk susceptibility should be further performed to guide disease prediction and prevention.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>CG participated in study design, DNA amplification, sequence reading, project coordination and manuscript drafting and revising. RM carried out the statistical analysis, reference collection, and manuscript drafting. NP and LP executed PCR set up, DNA amplification and sequence reading.</p><p>All authors have read and approved the manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>Special thanks go to the Molecular Biology staff of Bios Biotech Multi-Diagnostic Health Center (Rome, Italy), which has provided technical as well as financial support for this study.</p><p>This study was made possible by the Penn State University Physician-Scientist Stimulus Award and by the Dean's Pilot and Feasibility Grant, number D1BTH06321-01 from the Office for the Advancement of Tele health (OAT), Health Resources and Services Administration, DHHS. This project is funded, in part, under a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ujpal</surname><given-names>M</given-names></name><name><surname>Matos</surname><given-names>O</given-names></name><name><surname>Bibok</surname><given-names>G</given-names></name><name><surname>Somogyi</surname><given-names>A</given-names></name><name><surname>Szabo</surname><given-names>G</given-names></name><name><surname>Suba</surname><given-names>Z</given-names></name></person-group><article-title>Diabetes and oral tumors in Hungary: epidemiological correlations</article-title><source>Diabetes care</source><year>2004</year><volume>27</volume><issue>3</issue><fpage>770</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">14988300</pub-id><pub-id pub-id-type="doi">10.2337/diacare.27.3.770</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huxley</surname><given-names>R</given-names></name><name><surname>Ansary-Moghaddam</surname><given-names>A</given-names></name><name><surname>Berrington de Gonzalez</surname><given-names>A</given-names></name><name><surname>Barzi</surname><given-names>F</given-names></name><name><surname>Woodward</surname><given-names>M</given-names></name></person-group><article-title>Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies</article-title><source>British journal of cancer</source><year>2005</year><volume>92</volume><issue>11</issue><fpage>2076</fpage><lpage>2083</lpage><pub-id pub-id-type="pmid">15886696</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjc.6602619</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strickler</surname><given-names>HD</given-names></name><name><surname>Wylie-Rosett</surname><given-names>J</given-names></name><name><surname>Rohan</surname><given-names>T</given-names></name><name><surname>Hoover</surname><given-names>DR</given-names></name><name><surname>Smoller</surname><given-names>S</given-names></name><name><surname>Burk</surname><given-names>RD</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><article-title>The relation of type 2 diabetes and cancer</article-title><source>Diabetes technology &#x00026; therapeutics</source><year>2001</year><volume>3</volume><issue>2</issue><fpage>263</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">11478333</pub-id><pub-id pub-id-type="doi">10.1089/152091501300209633</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gudmundsson</surname><given-names>J</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Bergthorsson</surname><given-names>JT</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Manolescu</surname><given-names>A</given-names></name><name><surname>Rafnar</surname><given-names>T</given-names></name><name><surname>Gudbjartsson</surname><given-names>D</given-names></name><name><surname>Agnarsson</surname><given-names>BA</given-names></name><name><surname>Baker</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes</article-title><source>Nature genetics</source><year>2007</year><volume>39</volume><issue>8</issue><fpage>977</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">17603485</pub-id><pub-id pub-id-type="doi">10.1038/ng2062</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Andersen</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes</article-title><source>Nature genetics</source><year>2008</year><volume>40</volume><issue>5</issue><fpage>638</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">18372903</pub-id><pub-id pub-id-type="doi">10.1038/ng.120</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Jacobs</surname><given-names>KB</given-names></name><name><surname>Yeager</surname><given-names>M</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Wacholder</surname><given-names>S</given-names></name><name><surname>Orr</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Chatterjee</surname><given-names>N</given-names></name><name><surname>Welch</surname><given-names>R</given-names></name><name><surname>Hutchinson</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Multiple loci identified in a genome-wide association study of prostate cancer</article-title><source>Nature genetics</source><year>2008</year><volume>40</volume><issue>3</issue><fpage>310</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">18264096</pub-id><pub-id pub-id-type="doi">10.1038/ng.91</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gragnoli</surname><given-names>C</given-names></name></person-group><article-title>CHOP T/C and C/T haplotypes contribute to early-onset type 2 diabetes in Italians</article-title><source>Journal of cellular physiology</source><year>2008</year><volume>217</volume><issue>2</issue><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">18680108</pub-id><pub-id pub-id-type="doi">10.1002/jcp.21553</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batchvarova</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>XZ</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><article-title>Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153)</article-title><source>The EMBO journal</source><year>1995</year><volume>14</volume><issue>19</issue><fpage>4654</fpage><lpage>4661</lpage><pub-id pub-id-type="pmid">7588595</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozcan</surname><given-names>U</given-names></name><name><surname>Cao</surname><given-names>Q</given-names></name><name><surname>Yilmaz</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>AH</given-names></name><name><surname>Iwakoshi</surname><given-names>NN</given-names></name><name><surname>Ozdelen</surname><given-names>E</given-names></name><name><surname>Tuncman</surname><given-names>G</given-names></name><name><surname>Gorgun</surname><given-names>C</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name><name><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group><article-title>Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes</article-title><source>Science </source><year>2004</year><volume>306</volume><issue>5695</issue><fpage>457</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">15486293</pub-id><pub-id pub-id-type="doi">10.1126/science.1103160</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakatani</surname><given-names>Y</given-names></name><name><surname>Kaneto</surname><given-names>H</given-names></name><name><surname>Kawamori</surname><given-names>D</given-names></name><name><surname>Yoshiuchi</surname><given-names>K</given-names></name><name><surname>Hatazaki</surname><given-names>M</given-names></name><name><surname>Matsuoka</surname><given-names>TA</given-names></name><name><surname>Ozawa</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Hori</surname><given-names>M</given-names></name><name><surname>Yamasaki</surname><given-names>Y</given-names></name><etal></etal></person-group><article-title>Involvement of endoplasmic reticulum stress in insulin resistance and diabetes</article-title><source>The Journal of biological chemistry</source><year>2005</year><volume>280</volume><issue>1</issue><fpage>847</fpage><lpage>851</lpage><pub-id pub-id-type="pmid">15509553</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ariyama</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Tsuchiya</surname><given-names>T</given-names></name><name><surname>Okada</surname><given-names>S</given-names></name><name><surname>Oyadomari</surname><given-names>S</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name></person-group><article-title>Chop-deficient mice showed increased adiposity but no glucose intolerance</article-title><source>Obesity (Silver Spring, Md)</source><year>2007</year><volume>15</volume><issue>7</issue><fpage>1647</fpage><lpage>1656</lpage><pub-id pub-id-type="pmid">17636082</pub-id><pub-id pub-id-type="doi">10.1038/oby.2007.197</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zinszner</surname><given-names>H</given-names></name><name><surname>Kuroda</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Batchvarova</surname><given-names>N</given-names></name><name><surname>Lightfoot</surname><given-names>RT</given-names></name><name><surname>Remotti</surname><given-names>H</given-names></name><name><surname>Stevens</surname><given-names>JL</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><article-title>CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum</article-title><source>Genes &#x00026; development</source><year>1998</year><volume>12</volume><issue>7</issue><fpage>982</fpage><lpage>995</lpage><pub-id pub-id-type="pmid">9531536</pub-id><pub-id pub-id-type="doi">10.1101/gad.12.7.982</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crozat</surname><given-names>A</given-names></name><name><surname>Aman</surname><given-names>P</given-names></name><name><surname>Mandahl</surname><given-names>N</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><article-title>Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma</article-title><source>Nature</source><year>1993</year><volume>363</volume><issue>6430</issue><fpage>640</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">8510758</pub-id><pub-id pub-id-type="doi">10.1038/363640a0</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aman</surname><given-names>P</given-names></name></person-group><article-title>Fusion genes in solid tumors</article-title><source>Seminars in cancer biology</source><year>1999</year><volume>9</volume><issue>4</issue><fpage>303</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">10448117</pub-id><pub-id pub-id-type="doi">10.1006/scbi.1999.0130</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antonescu</surname><given-names>CR</given-names></name><name><surname>Elahi</surname><given-names>A</given-names></name><name><surname>Humphrey</surname><given-names>M</given-names></name><name><surname>Lui</surname><given-names>MY</given-names></name><name><surname>Healey</surname><given-names>JH</given-names></name><name><surname>Brennan</surname><given-names>MF</given-names></name><name><surname>Woodruff</surname><given-names>JM</given-names></name><name><surname>Jhanwar</surname><given-names>SC</given-names></name><name><surname>Ladanyi</surname><given-names>M</given-names></name></person-group><article-title>Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas</article-title><source>J Mol Diagn</source><year>2000</year><volume>2</volume><issue>3</issue><fpage>132</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">11229517</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hosaka</surname><given-names>T</given-names></name><name><surname>Nakashima</surname><given-names>Y</given-names></name><name><surname>Kusuzaki</surname><given-names>K</given-names></name><name><surname>Murata</surname><given-names>H</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Nakamata</surname><given-names>T</given-names></name><name><surname>Aoyama</surname><given-names>T</given-names></name><name><surname>Okamoto</surname><given-names>T</given-names></name><name><surname>Nishijo</surname><given-names>K</given-names></name><name><surname>Araki</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma</article-title><source>J Mol Diagn</source><year>2002</year><volume>4</volume><issue>3</issue><fpage>164</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">12169678</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>M</given-names></name><name><surname>Ishida</surname><given-names>T</given-names></name><name><surname>Horiuchi</surname><given-names>H</given-names></name><name><surname>Kida</surname><given-names>N</given-names></name><name><surname>Uozaki</surname><given-names>H</given-names></name><name><surname>Takeuchi</surname><given-names>H</given-names></name><name><surname>Tsuji</surname><given-names>K</given-names></name><name><surname>Imamura</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>S</given-names></name><name><surname>Machinami</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma</article-title><source>The American journal of pathology</source><year>1995</year><volume>147</volume><issue>5</issue><fpage>1221</fpage><lpage>1227</lpage><pub-id pub-id-type="pmid">7485386</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aman</surname><given-names>P</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Mandahl</surname><given-names>N</given-names></name><name><surname>Fioretos</surname><given-names>T</given-names></name><name><surname>Heim</surname><given-names>S</given-names></name><name><surname>Arheden</surname><given-names>K</given-names></name><name><surname>Willen</surname><given-names>H</given-names></name><name><surname>Rydholm</surname><given-names>A</given-names></name><name><surname>Mitelman</surname><given-names>F</given-names></name></person-group><article-title>Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11)</article-title><source>Genes, chromosomes &#x00026; cancer</source><year>1992</year><volume>5</volume><issue>4</issue><fpage>278</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">1283316</pub-id><pub-id pub-id-type="doi">10.1002/gcc.2870050403</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallus</surname><given-names>S</given-names></name><name><surname>Colombo</surname><given-names>P</given-names></name><name><surname>Scarpino</surname><given-names>V</given-names></name><name><surname>Zuccaro</surname><given-names>P</given-names></name><name><surname>Negri</surname><given-names>E</given-names></name><name><surname>Apolone</surname><given-names>G</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name></person-group><article-title>Overweight and obesity in Italian adults and an overview of trends since 1983</article-title><source>Eur J Clin Nutr </source><year>2004</year><volume>60</volume><issue>10</issue><fpage>1174</fpage><lpage>1179</lpage><pub-id pub-id-type="pmid">16639416</pub-id><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602433</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Micheli</surname><given-names>A</given-names></name><name><surname>Francisci</surname><given-names>S</given-names></name><name><surname>Krogh</surname><given-names>V</given-names></name><name><surname>Rossi</surname><given-names>AG</given-names></name><name><surname>Crosignani</surname><given-names>P</given-names></name></person-group><article-title>Cancer prevalence in Italian cancer registry areas: the ITAPREVAL study. ITAPREVAL Working Group</article-title><source>Tumori</source><year>1999</year><volume>85</volume><issue>5</issue><fpage>309</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">10665852</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Curtis</surname><given-names>D</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><article-title>Model-free analysis and permutation tests for allelic associations</article-title><source>Human heredity</source><year>2000</year><volume>50</volume><issue>2</issue><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">10799972</pub-id><pub-id pub-id-type="doi">10.1159/000022901</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Habener</surname><given-names>JF</given-names></name></person-group><article-title>CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription</article-title><source>Genes &#x00026; development</source><year>1992</year><volume>6</volume><issue>3</issue><fpage>439</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">1547942</pub-id><pub-id pub-id-type="doi">10.1101/gad.6.3.439</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>Y</given-names></name><name><surname>Fukuhara</surname><given-names>A</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Komuro</surname><given-names>R</given-names></name><name><surname>Shimomura</surname><given-names>I</given-names></name></person-group><article-title>Insulin induces chaperone and CHOP gene expressions in adipocytes</article-title><source>Biochem Biophys Res Commun </source><year>2008</year><volume>365</volume><issue>4</issue><fpage>826</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">18035047</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.11.045</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poitout</surname><given-names>V</given-names></name><name><surname>Robertson</surname><given-names>RP</given-names></name></person-group><article-title>Glucolipotoxicity: fuel excess and beta-cell dysfunction</article-title><source>Endocrine reviews</source><year>2008</year><volume>29</volume><issue>3</issue><fpage>351</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">18048763</pub-id><pub-id pub-id-type="doi">10.1210/er.2007-0023</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boru</surname><given-names>C</given-names></name><name><surname>Silecchia</surname><given-names>G</given-names></name><name><surname>Pecchia</surname><given-names>A</given-names></name><name><surname>Iacobellis</surname><given-names>G</given-names></name><name><surname>Greco</surname><given-names>F</given-names></name><name><surname>Rizzello</surname><given-names>M</given-names></name><name><surname>Basso</surname><given-names>N</given-names></name></person-group><article-title>Prevalence of cancer in Italian obese patients referred for bariatric surgery</article-title><source>Obesity surgery</source><year>2005</year><volume>15</volume><issue>8</issue><fpage>1171</fpage><lpage>1176</lpage><pub-id pub-id-type="pmid">16197792</pub-id><pub-id pub-id-type="doi">10.1381/0960892055002284</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pi-Sunyer</surname><given-names>FX</given-names></name></person-group><article-title>Comorbidities of overweight and obesity: current evidence and research issues</article-title><source>Med Sci Sports Exerc </source><year>1999</year><volume>31</volume><issue>11 Suppl</issue><fpage>S602</fpage><lpage>S608</lpage><pub-id pub-id-type="pmid">10593535</pub-id></citation></ref></ref-list></back></article> 